Costs for commercially insured adults prescribed second-line diabetes medications

David T. Liss*, Raymond H. Kang, Nicola Lancki, Matthew J. O'Brien, Amisha Wallia, Andrew J. Cooper, Sterling A. Harris, Emily D. Parker, Ronald T. Ackermann

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Costs for commercially insured adults prescribed second-line diabetes medications'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Agricultural and Biological Sciences

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions